Evidence-based and consented pathways for patients with inflammatory bowel diseases (IBD);Evidenzbasierte und interdisziplinär konsentierte versorgungspfade für patientinnen und patienten mit morbus Crohn oder colitis ulcerosa

Zeitschrift fur Gastroenterologie

Volumn 47, Issue 6, 2009, Pages 541-562

  Raspe, Helner ^a   Conrad, S ^a   Muche Borowski, C ^a  

^a Institut fur Sozialmedizin   (Germany)

Author keywords

Crohn's disease; Evidence based care; Guidelines; Inflammatory bowel diseases; Ulcerative colitis

Indexed keywords

CONSENSUS DEVELOPMENT; CROHN DISEASE; ENTERITIS; EVIDENCE BASED PRACTICE; FUNDING; HEALTH CARE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; MEDICAL DECISION MAKING; ONSET AGE; PATIENT DECISION MAKING; RELAPSE; REMISSION; REVIEW; SOCIAL CARE; ULCERATIVE COLITIS;

CRITICAL PATHWAYS; DELIVERY OF HEALTH CARE; EVIDENCE-BASED MEDICINE; GASTROENTEROLOGY; GERMANY; HUMANS; INFLAMMATORY BOWEL DISEASES; PATIENT EDUCATION AS TOPIC;

EID: 67650813170     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109323     Document Type: Review

References (203)

1. Roy MA. Inflammatory bowel disease. Surgical Clinics of North America 1997; 77 (6): 1419-1431
2. Sandler RS, Golden AL. Epidemiology of Crohn's disease. J Clin Gastroenterol 1986; 8 (2): 160-165
3. Shivananda S, Lennard-Jones J, Logan R et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaboration study on inflammatory bowel disease (EC-IBD). Gut 1996; 39: 690-697 (Pubitemid 26426470)
4. Irvine EJ. A critical Review of epidemiological studies in inflammatory bowel disease. Scan J Gatroenterol 2001; 36 (1): 2-15 (Pubitemid 32147176)
5. Drossman DA, Patrick DL, Mitchell CM et al. Health-related quality of life in inflammatory bowel disease - functional status and patients worries and concerns. Dig Dis Sci 1989; 34 (9): 1379-1386 (Pubitemid 19247394)
6. Berklev T, Jahnsen J, Schulz T et al. Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. Eur J Gastroenterol Hepatol 2005; 17: 1037-1045 (Pubitemid 41423996)
7. Raspe H, Lühmann D. Klinische und Versorgungsleitlinien. Z ärztl Fortbilb Qual sich 2002; 96: 212
8. Stange EF, Schreiber S, Fölsch U et al. Diagnostik und Therapie des Morbus Crohn. Z Gastroenterol 2003; 41: 19-68 (Sonderdruck)
9. Hoffmann JC, Zeitz M, Bischoff SC et al. Diagnostik und Therapie der Colitis Ulcerosa: Ergebnisse einer evidenzbasierten Konsensuskonferenz. Z Gastroenterol 2004; 42: 984-1032
10. Goebell H. Stellenwert von Aktivitätsindizes bei der Begutachtung von chronisch-entzündlichen Darmkrankheiten. Med Sach 2000; 96 (6): 176-178
11. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1627-1640 (Pubitemid 46722637)
12. World Health Organisation. International Classification of functioning, disability and health. Geneva: WHO, 2001
13. Klaus J, Armbrecht G, Steinkamp M et al. High prevalance of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002; 51: 654-658 (Pubitemid 35216851)
14. Reinshagen M, von Tirpitz C. Osteoporosis and other extraintestinal symptoms and complications of inflammatory bowel disease. Dig Dis 2003; 21: 138-145 (Pubitemid 37323492)
15. Mintz R, Feller E, Bahr RL et al. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 135-139 (Pubitemid 38332174)
16. Schulte CMS. Review article: bone disease in inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20: 43-49 (Pubitemid 39319246)
17. Itin PH, Rufli T. Hautsymptome bei Erkrankungen im Bereich des Magen-Darm-Trakts. Therapeutischen Umschau 1995; 52: 236-242
18. Fornaciari G, Salvarani C, Beltrami M et al. Musculoskeletal manifestations in inflammatory bowel disease. Can J Gastroenterol 2001; 15: 399-403 (Pubitemid 32684667)
19. Palm Ø, Moum B, Jahnsen J et al. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study/the IBSEN study). Rheumatology 2001; 40: 1256-1261
20. Husain A, Triadafilopoulos G. Communicating with patients with inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 444-450 (Pubitemid 39029191)
21. Deter HC, Rapf M, Gladisch R et al. Psychodiagnostische Verlaufsuntersuchungen vom Morbus-Crohn-Patienten während der internistischen Intensivbehandlung. Z Gastroenterol 1993; 31: 703-710 (Pubitemid 24019702)
22. North CS, Alpers DH. A review of studies of psychiatric factors in Crohn's disease: etiologic implications. Annals of Clinical Psychiatry 1994; 6 (2): 117-124 (Pubitemid 24312175)
23. Küchenhoff J, Manz R, Mathes L. Was beeinflusst den Krankheitsverlauf des Morbus Crohn? Nervenarzt 1995; 66: 41-48
24. Feiereis H. Zur Psychotherapie des M. Crohn. Langenbecks Arch Chir 1984; Kongressbericht: 364
25. Irvine EJ. Review article: patients' fears and unmet needs in inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 (Suppl 4): 54-59 (Pubitemid 39319248)
26. Irvine EJ. Quality of life in inflammatory bowel disease: Bias and other factors affecting scores. Scand J Gastroenterol 1995; 30 (Suppl 208): 136-140
27. Nordin K, Påhlman L, Larsson K et al. Health-related quality of life and psychological distress in a population-based sample of swedish patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 450-457 (Pubitemid 34274330)
28. Porcelli P, Zaka S, Centonze S et al. Psychological distress and levels of disease activity in inflammatory bowel disease. Ital J Gastroenterol 1994; 26: 111-115 (Pubitemid 24196090)
29. Guthrie E, Jackson J, Shaffer J et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 2002; 97: 1994-1999 (Pubitemid 34906848)
30. Acosta-Ramírez D, Pagán-Ocasio V, Torres EA et al. Profile of the inflammatory bowel disease patient with depressive disorder. PRHSJ 2001; 20 (3): 215-220
31. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987; 28: 1600-1604 (Pubitemid 18033067)
32. Farrokhyar F, Marshall JK, Easterbrook B et al. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006; 12 (1): 38-46 (Pubitemid 43032450)
33. Maunder RG, Greenberg GR. Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis. Inflamm Bowel disease 2004; 10: 632-636 (Pubitemid 39276473)
34. Leibig T, Wilke E, Feiereis H. Zur Persönlichkeitsstruktur von Patienten mit Colitis ulcerosa und Morbus Crohn, eine testpsychologische Untersuchung während der Krankheitsremission. Zsch psychosom Med 1985; 31: 380-392 (Pubitemid 16214212)
35. Maunder RG, Lancee WJ, Hunter JJ et al. Attachment insecurity mode-rates the relationship between disease activity and depressive symptoms in ulcerative colitis. Inflamm Bowel Dis 2005; 11: 919-926 (Pubitemid 41428851)
36. Mittermaier C, Dejaco C, Waldhoer T et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004; 66: 79-84 (Pubitemid 38146536)
37. Kurina LM, Golacre MJ, Yeates D et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 2001; 55: 716-720 (Pubitemid 32881818)
38. Simrén M, Axelsson J, Gillberg R et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002; 97: 389-396 (Pubitemid 34160766)
39. Addolorato G, Capristo E, Stefanini GF et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity and nutritional status. Scan J Gastroenterol 1997; 32: 1013-1021 (Pubitemid 27433665)
40. Porcelli P, Leoci C, Guerra V. A prospective study of relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol 1996; 31: 792-796 (Pubitemid 26255048)
41. Mardini HE, Kip KE, Wilson JW. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 2004; 49 (3): 492-497 (Pubitemid 38455480)
42. North CS, Alpers DH, Helzer JE et al. Do life events or depression exacerbate inflammatory bowel disease? Annals of Internal Medicine 1991; 114: 381-386
43. Porcelli P, Leoci C, Guerra V et al. A longitudinal study of alexithymia and psychological distress in inflammatory bowel disease. J Psychsom Res 1996; 41 (6): 569-573 (Pubitemid 27032930)
44. Arapakis G, Lyketsos CG, Gerolymatos K et al. Low dominance and high intropunitiveness in ulcerative colitis and irritable bowel syndrom. Psychother Psychosom 1986; 46: 171-176 (Pubitemid 17146120)
45. Riley SA, Mani V, Goodman MJ et al. Why do patients with ulcerative colitis relapse? Gut 1990; 31: 179-183
46. Helzer JE, Chammas S, Norland CC et al. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology 1984; 86: 324-330 (Pubitemid 14218586)
47. Robertson DAF, Ray J, Diamond I et al. Personality profile and affective state of patients with inflammatory bowel disease. Gut 1989; 30: 623-626 (Pubitemid 19147074)
48. Magni G, Bernasconi G, Mauro P et al. Psychiatric diagnosis in ulcerative colitis - a controlled study. British Journal of Psychiatry 1991; 158: 413-415
49. Tarter RE, Switala J, Carra J et al. Inflammatory bowel disease: psychiatric status of patients before and after disease onset. Int J Psychiatry in Medicine 1987; 17: 173-181 (Pubitemid 17145422)
50. Schwarz Sp, Blanchard EB, Berreman CF et al. Psychological aspects of irritable bowel syndrom: comparison with inflammatory bowel disease and nonpatient controls. Behav Res Ther 1993; 31: 297-304 (Pubitemid 23100467)
51. Cabré E, Gassull MA. Nutritional and metabolic issues in inflammatory bowel disease. Curr Opin Clin Nutr Metabol Care 2003; 6: 569-576 (Pubitemid 40684578)
52. Spiller GA, Freeman HJ. Recent advances in dietary fiber and colorectal disease. Am J Clin Nutr 1981; 34: 1145-1152 (Pubitemid 11035927)
53. Burke A, Lichtenstein GR, Rombeau JL. Nutrition and ulcerative colitis. Bailliére's Clinical Gastroenterology 1997; 11 (1): 153-174
54. Russel MG, Engels LG, Muris JW et al. 'Modern life' in the epidemiology of infammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998; 10: 243-249
55. Jowett SL, Seal CJ, Pearce MS et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 2004; 53: 1479-1484 (Pubitemid 39265269)
56. Brandes JW, Lorenz-Meyer H. Zuckerfreie Diät: Eine neue Perspektive zur Behandlung des Morbus Crohn. Z Gastroenterologie 1981; 19: 1-12
57. Bjørkkjær T, Brunborg LA, Arslan G et al. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scan J Gastroenterol 2004; 39: 1088-1094 (Pubitemid 39536398)
58. Arslan G, Brunborg LA, Frøyland L et al. Effect of duodenal seal oil administration in patients with inflammatory bowel disease. Lipids 2002; 37: 935-940 (Pubitemid 36026487)
59. Ganguli SC, Cawdron R, Irvine EJ. Alternative medicine use by Canadian ambulatory gastroenterology patients: Secular trend or epidemic? Am J Gastroneterol 2004; 99 (2): 319-326
60. Moser G, Tillinger W, Sachs G et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res 1996; 40 (5): 503-509 (Pubitemid 26174492)
61. Burgmann T, Rawsthorne P, Bernstein CN. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use? Am J Gastroenterol 2004; 99 (5): 889-893
62. Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002; 8: 174-179 (Pubitemid 34546043)
63. Hilsden RJ, Verhoef MJ, Best A et al. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol 2003; 98: 1563-1568 (Pubitemid 36875348)
64. Joos S, Brinkhaus B, Maluche C et al. Acupuncture and moxibustion in the treatment of active Crohn's disease: a randomized controlled study. Digestion 2004; 69: 131-139 (Pubitemid 38813022)
65. Cottone M. Stress and physical activity: are they risk factors for IBD? Ital J Gastroenterol Hepatol 1998; 30: 252-253
66. Levenstein S. Stress and ulcerative colitis: convincing the doubting thomases. AJG 2003; 98: 2112-2114 (Pubitemid 37305344)
67. Hershfield N. Hans Selye, inflammatory bowel disease and placebo response. Can J Gastroenterol 1997; 11 (7): 623-625 (Pubitemid 27466530)
68. Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet 2002; 359: 331-340
69. Drossmann DA. Presidential address: gastrointestinal illness and the biopsychosocial model. Psychosom Med 1998; 60: 258-267 (Pubitemid 28279969)
70. Niess JH, Mönnikes H, Dignass AU et al. Review on the influence of stress on immun mediators, neuropeptides and hormones with relevance for inflammatory bowel disease. Digestion 2002; 65: 131-140 (Pubitemid 34914032)
71. LeResche L, Dworkin SF. The role of stress in inflammatory bowel disease, including peridontal disease: review of concepts and current finding. Peridentology 2002; 30: 91-103
72. Levenstein S, Prantera C, Varva V et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95: 1213-1220 (Pubitemid 30263515)
73. Bitton A, Sewitch MJ, Peppercorn MA et al. Psychosocial determinant of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol 2003; 98: 2203-2208 (Pubitemid 37305360)
74. Li J, Nørgárd B, Hansen Precht D et al. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am J Gastroenterol 2004; 99 (6): 1129-1133 (Pubitemid 38917819)
75. von Wietersheim J, Overbeck A, Kiel K et al. Die Bedeutung rezidivauslösender Ereignisse bei Patienten mit chronisch entzündlichen Darmerkrankungen. Ergebnisse einer prospektiven Längsschnittstudie über 3 Jahre. Psychother Psychosom med Psychol 1994; 44: 58-64
76. Kosarz P, Traue HC. Alltagsstress und Colitis ulcerosa. Psychother Psychosom med Psychol 1997; 47: 117-122
77. Maunder RG. Evidence that stress contributes the inflammatory bowel disease: evaluation, synthesis, and future directions. Inflamm Bowel Dis 2005; 11 (6): 600-608 (Pubitemid 40826349)
78. Greene BR, Blanchard ED, Wan CK. Long-term monitoring od psychosocial stress amd symptomatology in inflammatory bowel disease. Behav Res Ther 1994; 32 (2): 217-226 (Pubitemid 24046577)
79. Garrett VD, Brantley PJ, Jones GN et al. The relation between daily stress and Crohn's disease. J Behav Med 1991; 14 (1): 87-96
80. Head KA, Jurenka JS. Inflammatory bowel disease part I: Ulcerative Colitis - pathophysiology and conventional and alternative treatment options. Altern Med Rev 2003; 8 (3): 247-283 (Pubitemid 37099887)
81. Krishnan A, Korzenik JR. Inflammatory bowel disease and environmental influences. Gastroenterol Clin N Am 2002; 31: 21-39 (Pubitemid 34733031)
82. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmunity Reviews 2004; 3: 394-400 (Pubitemid 38993362)
83. Peppercorn MA. Definition of and risk factors for inflammatory bowel disease. 2006. www.uptodate.com
84. Snapper SB, Podolsky DK. Epidemiology and genetic and environmental factors in inflammatory bowel disease. 2006. www.uptodate.com
85. Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517 (Pubitemid 38649869)
86. Irvine EJ, Farrokhyar F, Swarbrick ET. A critical review of epidemiological studies in inflammatory bowel disease. Scan J Gastroenterol 2001; 1: 2-15 (Pubitemid 32147176)
87. Nakamura Y, Kobayashi M, Nagai M et al. A case-control study of ulcerative colitis in Japan. J Clin Gastroenterol 1994; 18(1): 72-79 (Pubitemid 24004309)
88. Joachim G. Inflammatory bowel disease: effects on lifestyle. Journal of Advanced Nursing 1987; 12: 483-487
89. Hagerstown MD. Inflammatory bowel disease impact and patient characteristics. Gastroenterology nursing 1993; 15: 147-154
90. Kinash RG, Fischer DG, Luckie BE et al. Coping patterns and related characteristics in patients with IBD. Rehabilitation Nursing 1993; 18: 12-19
91. Herrmann U, Rose M, Klapp BF et al. Personale Ressourcen und Coping von Patienten mit chronisch entzündlichen Darmerkrankungen (CED). Z Med Psychol 2005; 14: 59-65
92. Martin A, Leone L, Castagliuolo I et al. What do patients want to know about their inflammatory bowel disease. Ital J Gastroenterol 1992; 24: 477-480 (Pubitemid 23042933)
93. O'Sullivan MA, Mahmud N, Kelleher DP et al. Patient knowledge and educational needs in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2000; 12: 39-43 (Pubitemid 30073890)
94. Polglase AL, McDermott FT, Hughes ESR. Ulcerative colitis and Crohn's disease - What your patient want to know. Australian Family Physician 1984; 13: 422-424
95. Zander W. Psychosomatische Grundlagenforschung: Theoretische Überlegungen und experimentelle Untersuchungen. Zschr psychosom Med 1982; 28: 126-128
96. Moser G. Psychosomatik in der Gastroenterologie. Wien Med Wschr 2000; 150: 209-212
97. Frenzer A, Binek J, Hammer B. Soziale Folgen und Lebensqualität bei Patienten mit chronisch entzündlichen Darmerkrankungen. Schweiz Med Wochenschr 1996; 126: 97S-99S (Pubitemid 26184832)
98. Lask B. Psychological aspects of inflammatory bowel disease. Wien Med Wschr 1986; 98: 544-546 (Pubitemid 16044862)
99. Ringel Y, Drossmann DA. Psychosocial aspects of Crohn's disease. Surgical Clinics of North America 2001; 81: 231-252
100. Küchenhoff J. Biopsychosoziale Wechselwirkungen im Krankheitsverlauf des Morbus Crohn. Zsch psychosom Med 1995; 43: 306-328
101. Karlinger K, Györke T, Makö E et al. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000; 35: 154-167 (Pubitemid 30734686)
102. Dudley-Brown S. Prevention of psychological distress in persons with inflammatory bowel disease. Issues in Mental Health Nursing 2002; 23: 403-422 (Pubitemid 33692385)
103. Casati J, Toner BB. Psychosocial aspects of inflammatory bowel disease. Biomed & Pharmacother 2000; 54: 388-393 (Pubitemid 30680451)
104. Murray JB. Psychological factors in ulcerative colitis. The Journal of General Psychology 1984; 110: 201-221
105. Gerbert B. Psychological aspects of Crohn's disease. J Behav Med 1980; 3: 41-58
106. Timmer A. Environmental influence on inflammatory bowel disease manifestation. Dig Dis 2003; 21: 91-104
107. Ringel Y, Drossmann DA. Psychosocial aspects of Crohn's disease. Surgical Clinics of North America 2001; 81 (1): 231-252
108. Zuckerman MJ, Briones DF. Inflammatory bowel disease: overview and psychosomatics. Texa Medicine 1989; 85: 32-36 (Pubitemid 19087167)
109. Enck P, Schäfer R. Psychosoziale Faktoren beim M. Crohn - eine Übersicht. Z Gastroenterol 1996; 34: 708-713
110. Sewitch MJ, Abrahamowicz M, Bitton A et al. Psychosocial correlates of patient-physician discordance in inflammatory bowel disease. Am J Gastroenterol 2002; 97: 2174-2183 (Pubitemid 35052028)
111. Turnbull GK, Vallis TM. Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function. Am J Gastroenterol 1995; 90: 1450-1454
112. Petrak F, Hardt J, Clement T et al. Impaired health-related quality of life in inflammatory bowel disease: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol 2001; 36: 375-382 (Pubitemid 32250733)
113. Walker EA, Gelfand MD, Gelfant AN et al. The relationship of current psychiatric disorders to functional disability and distress in patients with inflammatory bowel disease. General Hospital Psychiatry 1996; 18: 220-229 (Pubitemid 26251507)
114. Schwartz RA, Schwartz IK. Psychiatric disorders associated with Crohn's disease. Psychiatry in Medicine 1982; 12: 67-73
115. Mussell M, Böcker U, Nagel N et al. Predictors of disease-related concers and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004; 16: 1273-1280 (Pubitemid 39627525)
116. Paar GH, Bezzenberger U, Lorenz-Meyer H. Über den Zusammenhang von psychosazialem Stress und Krankheitsaktivität bei Patienten mit Morbus Crohn und Colitis ulcerosa. Z Gastroenterologie 1988; 26: 648-657 (Pubitemid 18265145)
117. Turnbull GK, Vallis TM. Quality of life in inflammatory bowel disease: the interaction of disease activity with psychosocial function. Am J Gastroenterol 1995; 90(9): 1450-1454
118. van der Eijk I, Vlachonikolis IG, Munkholm P et al. The role of qualitiy of care in health-related quality of life in patients with IBD. Inflamm Bowel Dis 2004; 10: 392-398 (Pubitemid 39036127)
119. Gerson MJ, Schonholtz J, Grega CH et al. The importance of the family context in inflammatory bowel disease. Mt Sinai J Med 1998; 65: 398-403 (Pubitemid 128472498)
120. Van Hemert A, Hengeveld MW, Bolk JH et al. Psychiatric disorders in relation to medical illness among patients of a general medical outpatient clinic. Psychological Medicine 1993; 23: 167-173 (Pubitemid 23250105)
121. Tanaka M, Kazuma K. Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission. J Clin Nurs 2005; 14: 65-73 (Pubitemid 40221631)
122. Sewitch MJ, Abrahamowicz M, Bitton A et al. Psychological distress, social support and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96 (5): 1470-1479 (Pubitemid 32455077)
123. Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005; 21: 499-508 (Pubitemid 40381499)
124. Levenstein S. Embracing complexity: what determines quality of life in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004; 16: 1253-1255 (Pubitemid 39627520)
125. Mussell M, Böcker U, Nagel N et al. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004; 16: 1273-1280 (Pubitemid 39627525)
126. Cuntz U et al. Determinanten der subjektiven Belastung durch Darmerkrankungen. Psychther Psychosom med Psychol 1999; 49: 493-500 (Pubitemid 30026292)
127. Barrett SML, Standen PJ, Lee AS et al. Personality, smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996; 8: 651-655 (Pubitemid 26241593)
128. Janke KH, Klump B, Gregor M et al. Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 272-286 (Pubitemid 40439682)
129. Pizzi LT, Weston CM, Goldfarb NI et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 47-52 (Pubitemid 43032451)
130. Deter HC, Manz R, Becker M et al. Soziale Unterstützung in der Beziehung zu körperlichen und seelischen Befunden bei Morbus Crohn-Patineten. Zsch psychosom Med 1991; 37: 45-59
131. Birtwistle J. The role of cigarette and nicotine in the onset and treatment of ulcerative colitis. Postgrad Med J 1996; 72: 714-718 (Pubitemid 27037829)
132. Timmer A, Sutherland LR, Martin F et al. Smoking, use of oral contraceptives, and medical induction of remission were rsik factors for relapse in Crohn's disease. Gut 1999; 44: 311-312 (Pubitemid 29119322)
133. Forbes A. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996; 8: 761-763
134. Zijlstra FJ. Smoking and nicotine in inflammatory bowel disease: good or bad for cytokines? Mediators of Inflammation 1998; 7: 153-155
135. Sercombe J. Inflammatory bowel disease and smoking. Professional Nurse 2000; 15 (7): 439-442
136. Miner PB. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol 1997; 92 (12): 1S-4S (Pubitemid 27521648)
137. Birrenbach T, Böcker U. Inflammatory bowel disease and smoking - a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004; 10: 848-859 (Pubitemid 39549299)
138. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol 2003; 98: 363-368 (Pubitemid 36232387)
139. Russel MG, Nieman FH, Bergers JM et al. South Limburg IBD Study Group: Cigarette smoking and quality of life in patients with inflammatory bowel disease. Eur J Gestroenterol Hepatol 1996; 8: 1075-1081
140. Bustamante M, Nos P, Hoyos M et al. Relationship between smoking and colonic involment in inflammatory bowel disease. Rev Esp Enferm Dig 1998; 90 (12): 837-840
141. Thomas GAO, Rhodes J, Green JT et al. Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J 2000; 76: 273-279 (Pubitemid 30223939)
142. Ashley MJ. Smoking and disease of the gastrointestinal system: An epidemiological review with special references to sex differences. Can J Gastroenterol 1997; 11 (4): 345-352 (Pubitemid 27263195)
143. Cosnes J, Carbonnel F, Carrat F et al. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999; 13: 1403-1411 (Pubitemid 29516251)
144. Abraham N, Selby W, Lazarus R et al. Is smoking an indirect risk factor for the development of ulcerative colitis? An age- and sex-matched case-control study. J Gastroenterol Hepatol 2003; 18: 139-146 (Pubitemid 36349858)
145. Yamamoto T, Keighley MRB. Smoking and disease recurrence after operation for Crohn's disease. British Journal of Surgery 2000; 87: 398-404 (Pubitemid 30192945)
146. Manguso F, Sanges M, Staiano T et al. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol 2004; 99 (2): 327-334 (Pubitemid 38279877)
147. Radford-Smith GL, Edwards JE, Purdie DM et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002; 51: 808-813 (Pubitemid 35408600)
148. Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn'disease. Aliment Pharmacol Ther 2005; 21: 921-931 (Pubitemid 40529727)
149. Breuer-Katschinski BD, Holländer N, Goebell H. Effect of cigarette smoking on the course of chrohn's disease. Eur J Gastroenterol Hepatol 1996; 8 (3): 225-228 (Pubitemid 126426319)
150. Corrao G, Tragnone A, Caprilli R et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Int J Epidemiol 1998; 27: 397-404 (Pubitemid 28336965)
151. Medina C, Vergara M, Casellas F et al. Influence of smoking habit in the surgery of inflammatory bowel disease. Rev Esp Enferm Dig 1998; 90 (11): 775-778 (Pubitemid 128619103)
152. Odes HS, Fich A, Reif S et al. Effects of current cigarette smoking on clinical course of Crohn's disease and Ulcerative colitis. Dig Dis Sci 2001; 46 (8): 1717-1721 (Pubitemid 32727104)
153. Fraga XF, Vergara M, Medina C et al. Effect of smoking on the presentation and clinical course of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997; 9: 683-687 (Pubitemid 27315620)
154. Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. J Clin Gastroenterol 2005; 39: 32-35 (Pubitemid 40041340)
155. Sicilia B. Environmental rsik factors and Crohn's disease: a population-based, case-control study in Spain. Digest Liver Dis 2001; 33: 762-767 (Pubitemid 34071467)
156. Cosnes J, Mion-Larmurier I, Afchain P et al. Gender differences in the response of colitis to smoking. Clin Gastroenterol Hepatol 2004; 2: 41-48 (Pubitemid 38165398)
157. Cosnes J, Carbonnel F, Beaugerie L et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996; 110: 424-431 (Pubitemid 26043875)
158. Cosnes J, Beaugerie L, Carbonnel F et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001; 120: 1093-1099 (Pubitemid 32246663)
159. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. Gastroenterology 1998; 114: 1143-1150 (Pubitemid 28243899)
160. de Rooy EC, Toner BB, Maunder RG et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 2001; 96: 1816-1821 (Pubitemid 32552365)
161. Drossman DA, Patrick DL, Mitchell CM et al.: Health-related quality of life in inflammatory bowel disease - functional status and patients worries and concerns. Dig Dis Sci 1989; 34 (9): 1379-1386 (Pubitemid 19247394)
162. Blondel-Kucharski F, Chircop C, Marquis P et al. Health-realted quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 2001; 96: 2915-2920 (Pubitemid 32959533)
163. Ananthakrishnan AN. Does it Matter Where You Are Hospitalized for Inflammatory Bowel Disease? A Nationwide Analysis of Hospital Volume. Digestive Disease Week 2008; Abstract #T1167 www.ddw.org; Stand: 21.7.2008
164. Indikationskatalog für Anschlussrehabilitation (AHB), Stand: 11.1.2008. http://www.deutsche-rentenversicherung-bund.de; Stand: 21.7.2008
165. Qualitätsberichte der Reha-Zentren der Deutschen Rentenversicherung Bund www.deutsche-rentenversicherung-bund.de
166. Deutsche Morbus Crohn/Colitis ulcerosa Vereinigung e.V. Verzeichnis der Rehabilitationskliniken bei Morbus Crohn und Colitis ulcerosa. DCCV, 2007
167. Jaghult S, Larson J, Wredling R et al. A multiprofessional education programme for patients with inflammatory bowel disease: a randomized controlled trial. Scand J Gastroenterol 2007; 42 (12): 1452-1459 (Pubitemid 350125543)
168. Oxelmark L, Magnusson A, Lofberg R et al. Group-based intervention program in inflammatory bowel disease patients: effects on quality of life. Inflamm Bowel Dis 2007; 13 (2): 182-190 (Pubitemid 46806227)
169. Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol 2005; 19 (4): 235-244 (Pubitemid 40778865)
170. Bregenzer N, Lange A, Furst A et al. Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being. Z Gastroenterol 2005; 43 (4): 367-371 (Pubitemid 40593381)
171. Brown SA. Studies of educational interventions and outcomes in diabetic adults: a meta-Analysis revisited. Patient Educ Couns 1990; 16: 189-215
172. Devine EC, Pearcy J. Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease. Patient Educ Couns 1996; 29: 167-178 (Pubitemid 26379290)
173. Devine EC, Reifschneider E. A meta-analysis of the effects of psychoeducational care in adults with hypertension. Nurs Res 1995; 44 (4): 237-245
174. Mazzuca SA. Does patient education in chronic disease have therapeutic value? J Chron Dis 1982; 35: 521-529 (Pubitemid 12085578)
175. Roter DL, Hall JA, Merisca R et al. Effectiveness of the interventions to improve patient compliance: a meta-analysis. Med Care 1998; 36 (8): 1138-1161 (Pubitemid 128456406)
176. Quon H, Present JW, Sutherland LR. Evaluation of educational programs in Inflammatory bowel disease. Inflamm Bowel Dis 2003; 9 (6): 356-362 (Pubitemid 37461446)
177. Verma S, Tsai HH, Giaffer MH. Does better disease-related education improve quality of life? A survey of IBD patients. Dig Dis Sci 2001; 46 (4): 865-869 (Pubitemid 32373109)
178. Jones SC, Gallacher B, Lobo AJ et al. A patient knowledge questionnaire in Inflammatory bowel disease. J Clin Gastroenterol 1993; 17 (1): 21-24 (Pubitemid 23193772)
179. Rezailashkajani M, Roshandel D, Ansari S et al. Knowledge of disease and health information needs of the patients with inflammatory bowel disease in a developing country. Int J Colorectal Dis 2006; 21 (5): 433-440
180. Gensichen J, Muth C, Buttzlaff M et al. Die Zukunft ist chronisch: Das Chronic Care-Modell in der deutschen Primärversorgung. Übergreifende Behandlungsrinzipien einer proaktiven Versorgung für chronische Kranke. Z ärztl Fortbild Qual Gesundhwes 2006; 100: 365-374
181. Classen M, Dierkesmann R, Heimpel H et al. Rationelle Diagnostik und Therapie in der Inneren Medizin München, Jena: Urban und Fischer, 2001
182. Moser G. Bedeutung von Stress und Depression bei chronisch entzündlichen Darmerkrankungen. J Gastroenterol Hepatol Erkr 2005; 3 (2): 26-30 (Pubitemid 40868151)
183. Kunzendorf S, Jantschek G, Straubinger K et al. The Luebeck Interview for Psychosocial Screening in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2007; 13 (1): 33-41 (Pubitemid 46080007)
184. Bjorkkjaer T, Brun JG, Valen M et al. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids Health Dis 2006; 5: 6 (Pubitemid 43797451)
185. Cozzi F, Podswiadek M, Cardianle G et al. Mud-bath treatment in spondylitis associated with inflammatory bowel disease - a pilot randomised clinical trial. Joint Bone Spine 2007; 74 (5): 436-439 (Pubitemid 47588968)
186. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007; 129 (1 -2): 210-223 (Pubitemid 46551386)
187. Koretz RL, Avenell A, Lipman TO et al. Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol 2007; 102 (2): 412-429 (Pubitemid 46160556)
188. Duffy LC, Zielezny MA, Marshall JR et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med 1991; 17 (3): 101-110
189. Hjortswang H, Järnerat G, Curman B et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2003; 15: 1011-1020 (Pubitemid 37094302)
190. Hjortswang H, Ström M, Almer S. Health-related quality of life in Swedish patients with ulcerative colitis. Am J Gastroenterol 1998; 93: 2203-2211 (Pubitemid 29076875)
191. Ng V, Millard W, Lebrun et al. Low-intensity exercise improves quality of life in patients with Crohn's disease. Clin J Sport Med 2007; 17 (5): 384-388 (Pubitemid 47415180)
192. Langhorst J, Mueller T, Luedtke R et al. Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up. Scand J Gastroenterol 2007; 42 (6): 734-745 (Pubitemid 46763582)
193. Elsenbruch S, Langhorst J, Popkirowa K et al. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 2005; 74 (5): 277-287 (Pubitemid 41160198)
194. Oliveira S, Zaltman C, Elia C et al. Quality-of-life measurement in patients with inflammatory bowel disease receiving social support. Inflamm Bowel Dis 2007; 13 (4): 470-474 (Pubitemid 46668253)
195. ÄZQ, AWMF. Deutsches Instrument zur methodischen Leitlinienbewertung 2005. www.delbi.de
196. Becker E, Horn S, Hussla B et al. Sozialmedizinische Leistungsbeurteilung bei chronisch entzündlichen Darmerkrankungen. In: Deutsche Gesellschaft für Sozialmedizin, autorisiert für elektronische Veröffentlichung (Hrsg) AWMF online, März 2005
197. Carter MJ, Lobo AJ, Travis SPL et al. Guideline of the management of inflammatory bowel disease in adults. Gut 2004; 53 (suppl V): v1-v16 (Pubitemid 39120096)
198. Caprilli R, Gassull MA, Escher JC et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006; 55 (Suppl I): i36-i58 (Pubitemid 43268292)
199. Stange EF, Travis SPL, Vermeire S et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55 (Suppl I): i1-i15 (Pubitemid 43268290)
200. Travis SPL, Stange EF, Lemann M et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006; 55 (Suppl I): i16-i35 (Pubitemid 43268291)
201. Centre for Evidence-based Medicine. Oxford Centre for Evidence-based Medicine Levels of Evidence 2001. www.cebm.net
202. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Das Leitlinien-Manual: Entwicklung und Implementierung von Leitlinien in der Medizin. Z Ärztl Fortbild Qualitätssich 2001; 95 (Suppl 1): 1-84
203. Scottish Intercollegiate Guidelines Network. Postal Address: SIGN, 28 Thistle Street, Edinburgh EH 2 1EN www.sign.ac.uk